Transcriptional and posttranscriptional regulations of the HLA-G gene

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Castelli, Erick C ^a   Veiga Castelli, Luciana C ^b   Yaghi, Layale ^c,d   Moreau, Philippe ^c,d   Donadi, Eduardo A ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK TRANSCRIPTION FACTOR 1; HLA G ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 2; INTERLEUKIN 10; JANUS KINASE 1; JANUS KINASE 2; LEUKEMIA INHIBITORY FACTOR; MULTIPROTEIN COMPLEX; NUCLEAR FACTOR Y; STAT1 PROTEIN; 3' UNTRANSLATED REGION; ISOPROTEIN; MESSENGER RNA; MICRORNA; PROTEIN BINDING;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CORPUS LUTEUM; CPG ISLAND; DNA POLYMORPHISM; GENE CONTROL; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC CODE; GENETIC VARIABILITY; HEMATOPOIETIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INDEL MUTATION; NIDATION; NONHUMAN; NUCLEOTIDE SEQUENCE; NULL ALLELE; POSTTRANSCRIPTIONAL CONTROL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REGULATOR GENE; REGULATORY MECHANISM; RETROPOSON; REVIEW; RNA STABILITY; SPONTANEOUS ABORTION; STOP CODON; TRANSACTIVATION; TRANSCRIPTION REGULATION; ALLELE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETICS; HAPLOTYPE; IMMUNOLOGY; OPEN READING FRAME; PROTEIN SYNTHESIS;

3' UNTRANSLATED REGIONS; ALLELES; GENE EXPRESSION REGULATION; HAPLOTYPES; HLA-G ANTIGENS; HUMANS; MICRORNAS; OPEN READING FRAMES; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84897548409     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/734068     Document Type: Review

References (160)

1. Donadi E. A., Castelli E. C., Arnaiz-Villena A., Roger M., Rey D., Moreau P., Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cellular and Molecular Life Sciences 2011 68 3 369 395 2-s2.0-79951550728 10.1007/s00018-010-0580-7
2. Shiroishi M., Kuroki K., Ose T., Rasubala L., Shiratori I., Arase H., Tsumoto K., Kumagai I., Kohda D., Maenaka K., Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. Journal of Biological Chemistry 2006 281 15 10439 10447 2-s2.0-33744524670 10.1074/jbc.M512305200 (Pubitemid 43864583)
3. Gregori S., Tomasoni D., Pacciani V., Scirpoli M., Battaglia M., Magnani C. F., Hauben E., Roncarolo M.-G., Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/ HLA-G pathway. Blood 2010 116 6 935 944 2-s2.0-80855128766 10.1182/blood-2011-08-377416
4. Boyson J. E., Erskine R., Whitman M. C., Chiu M., Lau J. M., Koopman L. A., Valter M. M., Angelisova P., Horejsí V., Strominger J. L., Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proceedings of the National Academy of Sciences of the United States of America 2002 99 25 16180 16185 2-s2.0-0037058924 10.1073/pnas.212643199 (Pubitemid 35462769)
5. Gonen-Gross T., Achdout H., Arnon T. I., Gazit R., Stern N., Hořejší V., Goldman-Wohl D., Yagel S., Mandelboim O., The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and β 2-microglobulin-free HLA-G molecules. Journal of Immunology 2005 175 8 4866 4874 2-s2.0-26844481034 (Pubitemid 41456368)
6. Castelli E. C., Mendes C. T. Jr., Veiga-Castelli L. C., Roger M., Moreau P., Donadi E. A., A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. Molecular Biology and Evolution 2011 28 11 3069 3086 2-s2.0-80155195725 10.1093/molbev/msr138
7. Ober C., Aldrich C. L., Chervoneva I., Billstrand C., Rahimov F., Gray H. L., Hyslop T., Variation in the HLA-G promoter region influences miscarriage rates. American Journal of Human Genetics 2003 72 6 1425 1435 2-s2.0-0037677738 10.1086/375501 (Pubitemid 36628382)
8. Tan Z., Shon A. M., Ober C., Evidence of balancing selection at the HLA-G promoter region. Human Molecular Genetics 2005 14 23 3619 3628 2-s2.0-28744446297 10.1093/hmg/ddi389 (Pubitemid 41754663)
9. Martinez-Laso J., Herraizb M. A., Pea J., Promoter sequences confirm the three different evolutionary lineages described for HLA-G. Human Immunology 2013 74 3 383 388
10. Kulski J. K., Dunn D. S., Gaudieri S., Shiina T., Inoko H., Genomic and phylogenetic analysis of the human CD1 and HLA class I multicopy genes. Journal of Molecular Evolution 2001 53 6 642 650 2-s2.0-0034781918 10.1007/s002390010251 (Pubitemid 32989418)
11. Nasef A., Mathieu N., Chapel A., Frick J., François S., Mazurier C., Boutarfa A., Bouchet S., Gorin N.-C., Thierry D., Fouillard L., Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 2007 84 2 231 237 2-s2.0-34547647603 10.1097/01.tp.0000267918. 07906.08 (Pubitemid 47205757)
12. Chen X.-L., Chen P., Jia Z.-Q., Liu Y.-N., Ma K.-T., Zhang Y.-Z., Zhou C.-Y., HLA expression in human fetal bone marrow mesenchymal stem cells. Beijing Da Xue Xue Bao 2006 38 6 597 602 2-s2.0-44849143444
13. Menier C., Rabreau M., Challier J.-C., Le Discorde M., Carosella E. D., Rouas-Freiss N., Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 2004 104 10 3153 3160 2-s2.0-8644289450 10.1182/blood-2004-03-0809 (Pubitemid 39507129)
14. Ito T., Ito N., Saathoff M., Stampachiacchiere B., Bettermann A., Bulfone-Paus S., Takigawa M., Nickoloff B. J., Paus R., Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. Journal of Investigative Dermatology 2005 125 6 1139 1148 2-s2.0-33644818887 10.1111/j.0022-202X.2005.23927.x
15. Cirulli V., Zalatan J., McMaster M., Prinsen R., Salomon D. R., Ricordi C., Torbett B. E., Meda P., Crisa L., The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 2006 55 5 1214 1222 2-s2.0-33745295348 10.2337/db05-0731 (Pubitemid 44195357)
16. Le Discorde M., Moreau P., Sabatier P., Legeais J.-M., Carosella E. D., Expression of HLA-G in human Cornea, an immune-privileged tissue. Human Immunology 2003 64 11 1039 1044 2-s2.0-0242609915 10.1016/j.humimm.2003.08.346 (Pubitemid 37413712)
17. Crisa L., McMaster M. T., Ishii J. K., Fisher S. J., Salomon D. R., Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. Journal of Experimental Medicine 1997 186 2 289 298 2-s2.0-0030876686 10.1084/jem.186.2.289 (Pubitemid 27328029)
18. Kovats S., Main E. K., Librach C., Stubblebine M., Fisher S. J., Demars R., A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990 248 4952 220 223 2-s2.0-0025706374 (Pubitemid 120031455)
19. Van Den Elsen P. J., Gobin S. J. P., Van Eggermond M. C. J. A., Peijnenburg A., Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics 1998 48 3 208 221 2-s2.0-0031876997 10.1007/s002510050425 (Pubitemid 28352187)
20. Gobin S. J. P., Keijsers V., Van Zutphen M., Van Den Elsen P. J., The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor B. Journal of Immunology 1998 161 5 2276 2283 2-s2.0-0032168354 (Pubitemid 28397039)
21. Gobin S. J. P., Van Zutphen M., Woltman A. M., Van Den Elsen P. J., Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. Journal of Immunology 1999 163 3 1428 1434 2-s2.0-0033179275 (Pubitemid 29352763)
22. Gobin S. J. P., Peijnenburg A., Van Eggermond M., Van Zutphen M., Van Den Berg R., Van Den Elsen P. J., The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and β 2-microglobulin genes. Immunity 1998 9 4 531 541 2-s2.0-0032192508 10.1016/S1074-7613(00)80636-6 (Pubitemid 28499204)
23. Van Den Elsen P. J., Peijnenburg A., Van Eggermond M. C. J. A., Gobin S. J. P., Shared regulatory elements in the promoters of MHC class I and class II genes. Immunology Today 1998 19 7 308 312 2-s2.0-0032126250 10.1016/S0167- 5699(98)01287-0 (Pubitemid 28322326)
24. van den Elsen P. J., Expression regulation of major histocompatibility complex class I and class II encoding genes. Frontiers in Immunology 2011 2 48
25. Gobin S. J. P., Van Den Elsen P. J., Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F and HLA-G. Human Immunology 2000 61 11 1102 1107 2-s2.0-0034502106 10.1016/S0198-8859(00)00198-1 (Pubitemid 32043886)
26. The 1000 Genomes Project Consortium, An integrated map of genetic variation from 1,092 human genomes. Nature 2012 491 7422 56 65
27. Castelli E. C., Mendes-Junior C. T., Deghaide N. H. S., De Albuquerque R. S., Muniz Y. C. N., Simes R. T., Carosella E. D., Moreau P., Donadi E. A., The genetic structure of 3′untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes and Immunity 2010 11 2 134 141 2-s2.0-77649335964 10.1038/gene.2009.74
28. Sabbagh A., Luisi P., Castelli E. C., Worldwide genetic variation at the 3′ untranslated region of the HLA-G gene: balancing selection influencing genetic diversity. Genes & Immunity 2013 10.1038/gene.2013.67
29. Girdlestone J., Isamat M., Gewert D., Milstein C., Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors. Proceedings of the National Academy of Sciences of the United States of America 1993 90 24 11568 11572 2-s2.0-0027131874 10.1073/pnas.90.24.11568 (Pubitemid 24008680)
30. Hakem R., Le Bouteiller P., Jezo-Bremond A., Harper K., Campese D., Lemonnier F. A., Differential regulation of HLA-A3 and HLA-B7 MHC class I genes by IFN is due to two nucleotide differences in their IFN response sequences. Journal of Immunology 1991 147 7 2384 2390 2-s2.0-0026055096
31. Schmidt H., Gekeler V., Haas H., Engler-Blum G., Steiert I., Probst H., Muller C. A., Differential regulation of HLA class I genes by interferon. Immunogenetics 1990 31 4 245 252 2-s2.0-0025326001 (Pubitemid 20132754)
32. Chu W., Gao J., Murphy W. J., Hunt J. S., A candidate interferon-gamma activated site (GAS element) in the HLA-G promoter does not bind nuclear proteins. Human Immunology 1999 60 11 1113 1118 2-s2.0-0032711835 10.1016/S0198-8859(99)00091-9
33. Chu W., Yang Y., Geraghty D. E., Hunt J. S., Interferons enhance HLA-G mRNA and protein in transfected mouse fibroblasts. Journal of Reproductive Immunology 1999 42 1 1 15 2-s2.0-0032943989 10.1016/S0165-0378(98)00077-1 (Pubitemid 29066846)
34. Lefebvre S., Berrih-Aknin S., Adrian F., Moreau P., Poea S., Gourand L., Dausset J., Carosella E. D., Paul P., A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN- β Journal of Biological Chemistry 2001 276 9 6133 6139 2-s2.0-0035794210 10.1074/jbc.M008496200
35. Steimle V., Durand B., Barras E., Zufferey M., Hadam M. R., Mach B., Reith W., A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes and Development 1995 9 9 1021 1032 2-s2.0-0029060373
36. Durand B., Sperisen P., Emery P., Barras E., Zufferey M., Mach B., Reith W., RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO Journal 1997 16 5 1045 1055 2-s2.0-0031055891 10.1093/emboj/16.5.1045 (Pubitemid 27113183)
37. Hake S. B., Masternak K., Kammerbauer C., Janzen C., Reith W., Steimle V., CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Molecular and Cellular Biology 2000 20 20 7716 7725 2-s2.0-0033801751 10.1128/MCB.20.20.7716-7725.2000
38. Scholl T., Mahanta S. K., Strominger J. L., Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proceedings of the National Academy of Sciences of the United States of America 1997 94 12 6330 6334 2-s2.0-0030924770
39. Gobin S. J. P., Biesta P., De Steenwinkel J. E. M., Datema G., Van Den Elsen P. J., HLA-G transactivation by cAMP-response element-binding protein (CREB). An alternative transactivation pathway to the conserved major histocompatibility complex (MHC) class I regulatory routes. Journal of Biological Chemistry 2002 277 42 39525 39531 2-s2.0-0037131266 10.1074/jbc.M112273200 (Pubitemid 35190930)
40. Gobin S. J. P., Van Zutphen M., Westerheide S. D., Boss J. M., Van den Elsen P. J., The MHC-specific enhanceosome and its role in MHC class I and β 2-microglobulin gene transactivation. Journal of Immunology 2001 167 9 5175 5184 2-s2.0-0035500643 (Pubitemid 33009754)
41. Gobin S. J. P., Peijnenburg A., Keijsers V., Van Den Elsen P. J., Site α is crucial for two routes of IFN γ -induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 1997 6 5 601 611 2-s2.0-0030927280 10.1016/S1074-7613(00)80348-9 (Pubitemid 27239351)
42. Lefebvre S., Moreau P., Dausset J., Carosella E. D., Paul P., Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA. Placenta 1999 20 4 293 301 2-s2.0-0033135321 10.1053/plac.1998.0380 (Pubitemid 29199645)
43. Martin B. K., Chin K.-C., Olsen J. C., Skinner C. A., Dey A., Ozato K., Ting J. P.-Y., Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 1997 6 5 591 600 2-s2.0-0030982711 10.1016/S1074-7613(00)80347-7 (Pubitemid 27239350)
44. Meissner T. B., Li A., Biswas A., Lee K.-H., Liu Y.-J., Bayir E., Iliopoulos D., Van Den Elsen P. J., Kobayashi K. S., NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proceedings of the National Academy of Sciences of the United States of America 2010 107 31 13794 13799 2-s2.0-77956372057 10.1073/pnas.1008684107
45. Neerincx A., Rodriguez G. M., Steimle V., Kufer T. A., NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner. The Journal of Immunology 2012 188 10 4940 4950
46. Staehli F., Ludigs K., Heinz L. X., Seguín-Estévez Q., Ferrero I., Braun M., Schroder K., Rebsamen M., Tardivel A., Mattmann C., MacDonald H. R., Romero P., Reith W., Guarda G., Tschopp J., NLRC5 deficiency selectively impairs MHC class idependent lymphocyte killing by cytotoxic T cells. Journal of Immunology 2012 188 8 3820 3828 2-s2.0-84860316429 10.4049/jimmunol.1102671
47. Rousseau P., Masternak K., Krawczyk M., Reith W., Dausset J., Carosella E. D., Moreau P., In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner. Immunology 2004 111 1 53 65 2-s2.0-0346496125 10.1111/j.1365-2567.2004.01783.x (Pubitemid 38091050)
48. Solier C., Mallet V., Lenfant F., Bertrand A., Huchenq A., Le Bouteiller P., HLA-G unique promoter region: functional implications. Immunogenetics 2001 53 8 617 625 2-s2.0-0035217782 10.1007/s00251-001-0373-0 (Pubitemid 33152521)
49. Gobin S. J. P., Keijsers V., Cheong C., Van Zutphen M., Van Den Elsen P. J., Transcriptional regulation of HLA-G. Transplantation Proceedings 1999 31 4 1857 1859 2-s2.0-0032992622 10.1016/S0041-1345(99)00188-8 (Pubitemid 29275483)
50. Gobin S. J. P., Van den Elsen P. J., The regulation of HLA class I expression: is HLA-G the odd one out? Seminars in Cancer Biology 1999 9 1 55 59 2-s2.0-0033081294 10.1006/scbi.1998.0109 (Pubitemid 29178544)
51. Ibrahim E. C., Morange M., Dausset J., Carosella E. D., Paul P., Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines. Cell Stress and Chaperones 2000 5 3 207 218 2-s2.0-0033664159
52. Yie S.-M., Li L.-H., Li G.-M., Xiao R., Librach C. L., Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro. Human Reproduction 2006 21 1 46 51 2-s2.0-29144466744 10.1093/humrep/dei305 (Pubitemid 41794290)
53. Yie S.-M., Xiao R., Librach C. L., Progesterone regulates HLA-G gene expression through a novel progesterone response element. Human Reproduction 2006 21 10 2538 2544 2-s2.0-33749584353 10.1093/humrep/del126 (Pubitemid 44542144)
54. Schmidt C. M., Ehlenfeldt R. G., Athanasiou M. C., Duvick L. A., Heinrichs H., David C. S., Orr H. T., Extraembryonic expression of the human MHC class I gene HLA-G in transgenic mice: Evidence for a positive regulatory region located 1 kilobase 5' to the start site of transcription. Journal of Immunology 1993 151 5 2633 2645 2-s2.0-0027247977 (Pubitemid 23264515)
55. Yelavarthi K. K., Schmidt C. M., Ehlenfeldt R. G., Orr H. T., Hunt J. S., Cellular distribution of HLA-G mRNA in transgenic mouse placentas. Journal of Immunology 1993 151 7 3638 3645 2-s2.0-0027308192 (Pubitemid 23282675)
56. Moreau P., Lefebvre S., Gourand L., Dausset J., Carosella E. D., Paul P., Specific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver. Human Immunology 1998 59 12 751 757 2-s2.0-0032402365 10.1016/S0198-8859(98)00081-0 (Pubitemid 28512542)
57. Moreau P., Paul P., Gourand L., Prost S., Dausset J., Carosella E., Kirszenbaum M., HLA-G gene transcriptional regulation in trophoblasts and blood cells: differential binding of nuclear factors to a regulatory element located 1.1 kb from exon 1. Human Immunology 1997 52 1 41 46 2-s2.0-0031035482 10.1016/S0198-8859(96)00242-X (Pubitemid 27053845)
58. Flajollet S., Poras I., Carosella E. D., Moreau P., RREB-1 is a transcriptional repressor of HLA-G. Journal of Immunology 2009 183 11 6948 6959 2-s2.0-73349141408 10.4049/jimmunol.0902053
59. Shi Y., Sawada J.-I., Sui G., Affar E. B., Whetstine J. R., Lan F., Ogawa H., Luke M. P.-S., Nakatani Y., Shi Y., Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 2003 422 6933 735 738 2-s2.0-0242669199 10.1038/nature01550 (Pubitemid 36514114)
60. Deschaseaux F., Gaillard J., Langonné A., Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue. The FASEB Journal 2013 27 8 2977 2987
61. Ikeno M., Suzuki N., Kamiya M., LINE1 family member is negative regulator of HLA-G expression. Nucleic Acids Research 2012 40 21 10742 10752
62. Red-Horse K., Zhou Y., Genbacev O., Prakobphol A., Foulk R., McMaster M., Fisher S. J., Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. Journal of Clinical Investigation 2004 114 6 744 754 2-s2.0-9644254252 10.1172/JCI200422991 (Pubitemid 39578730)
63. Nagamatsu T., Fujii T., Yamashita T., Miki A., Kanai T., Kusumi M., Osuga Y., Kozuma S., Taketani Y., Hypoxia does not reduce HLA-G expression on extravillous cytotrophoblasts. Journal of Reproductive Immunology 2004 63 2 85 95 2-s2.0-4544260529 10.1016/j.jri.2004.07.001 (Pubitemid 39233633)
64. Chang C.-C., Ferrone S., HLA-G in melanoma: can the current controversies be solved? Seminars in Cancer Biology 2003 13 5 361 369 2-s2.0-0242587793 10.1016/S1044-579X(03)00027-0 (Pubitemid 38160935)
65. Chang C.-C., Murphy S. P., Ferrone S., Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms. Human Immunology 2003 64 11 1057 1063 2-s2.0-0242525165 10.1016/j.humimm.2003.08.357 (Pubitemid 37413715)
66. Mouillot G., Marcou C., Zidi I., Guillard C., Sangrouber D., Carosella E. D., Moreau P., Hypoxia modulates HLA-G gene expression in tumor cells. Human Immunology 2007 68 4 277 285 2-s2.0-34047131634 10.1016/j.humimm.2006.10.016 (Pubitemid 46509544)
67. Wenger R. H., Stiehl D. P., Camenisch G., Integration of oxygen signaling at the consensus HRE. Science's STKE 2005 2005 306, article re12 2-s2.0-31444444162
68. Moreau P., Adrian-Cabestre F., Menier C., Guiard V., Gourand L., Dausset J., Carosella E. D., Paul P., IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. International Immunology 1999 11 5 803 811 2-s2.0-0032913576 10.1093/intimm/11.5.803 (Pubitemid 29237771)
69. Urosevic M., Willers J., Mueller B., Kempf W., Burg G., Dummer R., HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 2002 99 2 609 617 2-s2.0-0037079713 10.1182/blood.V99.2.609 (Pubitemid 34533099)
70. Matsuda M., Salazar F., Petersson M., Masucci G., Hansson J., Pisa P., Zhang-Q. J., Masucci M. G., Kiessling R., Interleukin 10 pretreatment protects target cells from tumor- and allo- specific cytotoxic T cells and downregulates HLA class I expression. Journal of Experimental Medicine 1994 180 6 2371 2376 2-s2.0-0027959417 10.1084/jem.180.6.2371 (Pubitemid 24351621)
71. Moreau P., Faure O., Lefebvre S., Ibrahim E. G., O'Brien M., Gourand L., Dausset J., Carosella E. D., Paul P., Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts. Transplantation Proceedings 2001 33 3 2277 2280 2-s2.0-0035344601 (Pubitemid 33762710)
72. Amiot L., Onno M., Drénou B., Monvoisin C., Fauchet R., HLA-G class I gene expression in normal and malignant hematopoietic cells. Human Immunology 1998 59 8 524 528 2-s2.0-0031880227 10.1016/S0198-8859(98)00041-X (Pubitemid 28354973)
73. Onno M., Le Friec G., Pangault C., Amiot L., Guilloux V., Drénou B., Caulet-Maugendre S., André P., Fauchet R., Modulation of HLA-G antigens expression in myelomonocytic cells. Human Immunology 2000 61 11 1086 1094 2-s2.0-0034509291 10.1016/S0198-8859(00)00191-9 (Pubitemid 32043884)
74. Bamberger A.-M., Henatschke S., Schulte H. M., Löning T., Bamberge C. M., Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells. Journal of Clinical Endocrinology and Metabolism 2000 85 10 3932 3936 2-s2.0-0033766802
75. Shido F., Ito T., Nomura S., Yamamoto E., Sumigama S., Ino K., Itakura A., Hattori A., Tsujimoto M., Mizutani S., Kikkawa F., Endoplasmic reticulum aminopeptidase-1 mediates leukemia inhibitory factor-induced cell surface human leukocyte antigen-G expression in JEG-3 choriocarcinoma cells. Endocrinology 2006 147 4 1780 1788 2-s2.0-33645506651 10.1210/en.2005-1449
76. Rizzo R., Rubini M., Govoni M., Padovan M., Melchiorri L., Stignani M., Carturan S., Ferretti S., Trotta F., Baricordi O. R., HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenetics and Genomics 2006 16 9 615 623 2-s2.0-33747091959 10.1097/01.fpc.0000230115. 41828.3a (Pubitemid 44223073)
77. Hviid T. V. F., Rizzo R., Christiansen O. B., Melchiorri L., Lindhard A., Baricordi O. R., HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004 56 3 135 141 2-s2.0-3142706694 (Pubitemid 38916317)
78. Hviid T. V. F., Rizzo R., Melchiorri L., Stignani M., Baricordi O. R., Polymorphism in the 5′ upstream regulatory and 3′ untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Human Immunology 2006 67 1-2 53 62 2-s2.0-33646347407 10.1016/j.humimm.2005.12. 003 (Pubitemid 43673915)
79. Hviid T. V. F., Sørensen S., Morling N., Polymorphism in the regulatory region located more than 1.1 Kilobases 5' to the start site of transcription, the promoter region, and exon 1 of the HLA-G gene. Human Immunology 1999 60 12 1237 1244 2-s2.0-0033388872 10.1016/S0198-8859(99)00130-5 (Pubitemid 30017506)
80. Tureck L. V., Santos L. C., Wowk P. F., HLA-G 5′ URR SNPs and 3′ UTR 14-bp insertion/deletion polymorphism in an Afro-Brazilian population from Parana State. Int J Immunogenet 2014 41 1 29 33
81. da Silva J. S., Slowik R., Bicalho Mda G., Considerations on regulatory sequences of the distal promoter region of the HLA-G gene. Human Immunology 2013 74 4 473 477
82. Langat D. K., Morales P. J., Fazleabas A. T., Hunt J. S., Potential regulatory sequences in the untranslated regions of the baboon MHC class Ib gene, Paan-AG, more closely resemble those in the human MHC class Ia genes than those in the class Ib gene, HLA-G. Immunogenetics 2004 56 9 657 666 2-s2.0-11944254641 10.1007/s00251-004-0727-5 (Pubitemid 40100799)
83. Langat D. K., Morales P. J., Omwandho C. O., Fazleabas A. T., Polymorphisms in the Paan-AG promoter influence NF- B binding and transcriptional activity. Immunogenetics 2007 59 5 359 366 2-s2.0-34047232321 10.1007/s00251-007-0203-0 (Pubitemid 46537504)
84. Ober C., Billstrand C., Kuldanek S., Tan Z., The miscarriage-associated HLA-G -725G allele influences transcription rates in JEG-3 cells. Human Reproduction 2006 21 7 1743 1748 2-s2.0-33745841346 10.1093/humrep/del036 (Pubitemid 44028244)
85. Jassem R. M., Shani W. S., Loisel D. A., Sharief M., Billstrand C., Ober C., HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq. Human Immunology 2012 73 8 811 817
86. Misra M. K., Prakash S., Kapoor R., Pandey S. K., Sharma R. K., Agrawal S., Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease. Tissue Antigens 2013 82 5 317 326
87. Wiśniewski A., Biliń M., Klimczak A., Wagner M., Majorczyk E., Nowak I., Pokryszko-Dragan A., Kuśnierczyk P., Association of the HLA-G gene polymorphism with multiple sclerosis in a Polish population. International Journal of Immunogenetics 2010 37 4 307 311 2-s2.0-78651092675 10.1111/j.1744-313X.2010.00926.x
88. Nicolae D., Cox N. J., Lester L. A., Schneider D., Tan Z., Billstrand C., Kuldanek S., Donfack J., Kogut P., Patel N. M., Goodenbour J., Howard T., Wolf R., Koppelman G. H., White S. R., Parry R., Postma D. S., Meyers D., Bleecker E. R., Hunt J. S., Solway J., Ober C., Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. American Journal of Human Genetics 2005 76 2 349 357 2-s2.0-19944433619 10.1086/427763 (Pubitemid 40129561)
89. Kim S. K., Hong M. S., Shin M. K., Uhm Y. K., Chung J.-H., Lee M.-H., Promoter polymorphisms of the HLA-G gene, but not the HLA-E and HLA-F genes, is associated with non-segmental vitiligo patients in the Korean population. Archives of Dermatological Research 2011 303 9 679 684 2-s2.0-80755129046 10.1007/s00403-011-1160-x
90. Onno M., Amiot L., Bertho N., Drenou B., Fauchet R., CpG methylation patterns in the 5' part of the nonclassical HLA-G gene in peripheral blood CD34+ cells and CD2+ lymphocytes. Tissue Antigens 1997 49 4 356 364 2-s2.0-0030905449 (Pubitemid 27174286)
91. Guillaudeux T., Rodriguez A.-M., Girr M., Mallet V., Ellis S. A., Sargent I. L., Fauchet R., Alsat E., Le Bouteiller P., Methylation status and transcriptional expression of the MHC class I loci in human trophoblast cells from term placenta. Journal of Immunology 1995 154 7 3283 3299 2-s2.0-0028954008
92. Boucraut J., Guillaudeux T., Alizadeh M., Borretto J., Chimini G., Malecaze F., Semana G., Fauchet R., Pontarotti P., Le Bouteiller P., HLA-E is the only class I gene that escapes CpG methylation and is transcriptionally active in the trophoblast-derived human cell line JAR. Immunogenetics 1993 38 2 117 130 2-s2.0-0027159086 (Pubitemid 23197159)
93. Moreau P., Mouillot G., Rousseau P., Marcou C., Dausset J., Carosella E. D., HLA-G gene repression is reversed by demethylation. Proceedings of the National Academy of Sciences of USA 2003 100 3 1191 1196 (Pubitemid 36183978)
94. Mouillot G., Marcou C., Rousseau P., Rouas-Freiss N., Carosella E. D., Moreau P., HLA-G gene activation in tumor cells involves cis-acting epigenetic changes. International Journal of Cancer 2005 113 6 928 936 2-s2.0-11844269318 10.1002/ijc.20682 (Pubitemid 40096872)
95. Wastowski I. J., Simes R. T., Yaghi L., Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2′-deoxycytidine and interferon-gamma treatments: results from a multicentric study. The American Journal of Pathology 2013 182 2 540 552
96. Polakova K., Bandzuchova E., Tirpakova J., Kuba D., Russ G., Modulation of HLA-G expression. Neoplasma 2007 54 6 455 462 2-s2.0-38949143784
97. Seliger B., Schlaf G., Structure, expression and function of HLA-G in renal cell carcinoma. Seminars in Cancer Biology 2007 17 6 444 450 2-s2.0-35748951881 10.1016/j.semcancer.2007.07.001 (Pubitemid 350052590)
98. Holling T. M., Bergevoet M. W. T., Wierda R. J., Van Eggermond M. C. J. A., Van Den Elsen P. J., Genetic and epigenetic control of the major histocompatibility complex class Ib Gene HLA-G in Trophoblast cell lines. Annals of the New York Academy of Sciences 2009 1173 538 544 2-s2.0-70049107371 10.1111/j.1749-6632.2009.04660.x
99. Struhl K., Histone acetylation and transcriptional regulatory mechanisms. Genes and Development 1998 12 5 599 606 2-s2.0-0032030770 (Pubitemid 28134293)
100. Grunstein M., Histone acetylation in chromatin structure and transcription. Nature 1997 389 6649 349 352 2-s2.0-0030798245 10.1038/38664 (Pubitemid 27415209)
101. Veit T. D., Cazarolli J., Salzano F. M., Schiengold M., Chies J. A. B., New evidence for balancing selection at the HLA-G locus in South Amerindians. Genetics and Molecular Biology 2012 35 4, supplement 919 923
102. Santos K. E., Lima T. H., Felício L. P., Insights on the HLA-G evolutionary history provided by a Nearby Alu insertion. Molecular Biology and Evolution 2013 30 11 2423 2434
103. Geraghty D. E., Koller B. H., Orr H. T., A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proceedings of the National Academy of Sciences of the United States of America 1987 84 24 9145 9149 2-s2.0-0023475627
104. Kuersten S., Goodwin E. B., The power of the 3′ UTR: translational control and development. Nature Reviews Genetics 2003 4 8 626 637 2-s2.0-0042968976 10.1038/nrg1125 (Pubitemid 36917504)
105. Alvarez M., Piedade J., Balseiro S., Ribas G., Regateiro F., HLA-G 3′-UTR SNP and 14-bp deletion polymorphisms in Portuguese and Guinea-Bissau populations. International Journal of Immunogenetics 2009 36 6 361 366 2-s2.0-75549087354 10.1111/j.1744-313X.2009.00875.x
106. Castelli E. C., Moreau P., Chiromatzo A. O. E., Mendes-Junior C. T., Veiga-Castelli L. C., Yaghi L., Giuliatti S., Carosella E. D., Donadi E. A., In silico analysis of microRNAS targeting the HLA-G 3′ untranslated region alleles and haplotypes. Human Immunology 2009 70 12 1020 1025 2-s2.0-70350702674 10.1016/j.humimm.2009.07.028
107. Benfey P. N., MicroRNA is here to stay. Nature 2003 425 6955 244 245 2-s2.0-0142008720 (Pubitemid 37158385)
108. Yang M., Mattes J., Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacology and Therapeutics 2008 117 1 94 104 2-s2.0-36749094533 10.1016/j.pharmthera.2007.08.004 (Pubitemid 350199690)
109. Lee R. C., Feinbaum R. L., Ambros V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993 75 5 843 854 2-s2.0-0027751663 10.1016/0092-8674(93)90529-Y (Pubitemid 24014542)
110. Griffiths-Jones S., miRBase: the microRNA sequence database. Methods in Molecular Biology 2006 342 129 138 2-s2.0-33749059160
111. Griffiths-Jones S., Grocock R. J., van Dongen S., Bateman A., Enright A. J., miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Research 2006 34 D140 D144 2-s2.0-33644750115
112. Hviid T. V. F., Hylenius S., Lindhard A., Christiansen O. B., Association between human leukocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome. Tissue Antigens 2004 64 1 66 69 2-s2.0-3042698491 10.1111/j.1399-0039.2004.00239.x (Pubitemid 38850369)
113. Hiby S. E., King A., Sharkey A., Loke Y. W., Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens 1999 53 1 1 13 2-s2.0-0033005295 10.1034/j.1399-0039.1999.530101.x (Pubitemid 29084169)
114. Lucena-Silva N., de Souza V. S., Gomes R. G., HLA-G 3′ untranslated region polymorphisms are associated with systemic lupus erythematosus in 2 Brazilian populations. The Journal of Rheumatology 2013 40 7 1104 1113
115. Lucena-Silva N., Monteiro A. R., de Albuquerque R. S., Gomes R. G., Mendes-Junior C. T., Castelli E. C., Donadi E. A., Haplotype frequencies based on eight polymorphic sites at the 3' untranslated region of the HLA-G gene in individuals from two different geographical regions of Brazil. Tissue Antigens 2012 79 4 272 278 2-s2.0-84857781949 10.1111/j.1399-0039.2012.01842.x
116. Sabbagh A., Courtin D., Milet J., Association of HLA-G 3′ untranslated region polymorphisms with antibody response against Plasmodium falciparum antigens: preliminary results. Tissue Antigens 2013 82 1 53 58
117. Garcia A., Milet J., Courtin D., Association of HLA-G 3′ UTR polymorphisms with response to malaria infection: a first insight. Infection, Genetics and Evolution 2013 16 263 269
118. Courtin D., Milet J., Sabbagh A., HLA-G 3′ UTR-2 haplotype is associated with Human African trypanosomiasis susceptibility. Infection, Genetics and Evolution 2013 17 1 7
119. Sizzano F., Testi M., Zito L., Crocchiolo R., Troiano M., Mazzi B., Turchiano G., Torchio M., Pultrone C., Gregori S., Chiesa R., Gaziev J., Sodani P., Marktel S., Amoroso A., Roncarolo M. G., Lucarelli G., Ciceri F., Andreani M., Fleischhauer K., Genotypes and haplotypes in the 3′ untranslated region of the HLA-G gene and their association with clinical outcome of hematopoietic stem cell transplantation for beta-thalassemia. Tissue Antigens 2012 79 5 326 332 2-s2.0-84859583274 10.1111/j.1399-0039.2012.01862.x
120. Di Cristofaro J., El Moujallya D., Agnela A., HLA-G haplotype structure shows good conservation between different populations and good correlation with high, normal and low soluble HLA-G expression. Human Immunology 2013 74 2 203 206
121. Larsen M. H., Hylenius S., Andersen A.-M. N., Hviid T. V. F., The 3′-untranslated region of the HLA-G gene in relation to pre-eclampsia: revisited. Tissue Antigens 2010 75 3 253 261 2-s2.0-76249091273 10.1111/j.1399-0039.2009.01435.x
122. Harrison G. A., Humphrey K. E., Jakobsen I. B., Cooper D. W., A 14 bp deletion polymorphism in the HLA-G gene. Human Molecular Genetics 1993 2 12 2200 2-s2.0-0027770882 (Pubitemid 24003437)
123. Rebmann V., Van Der Ven K., Päßler M., Pfeiffer K., Krebs D., Grosse-Wilde H., Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001 57 1 15 21 2-s2.0-0035130652 10.1034/j.1399-0039.2001. 057001015.x (Pubitemid 32151071)
124. Svendsen S. G., Hantash B. M., Zhao L., The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3′-untranslated region. Human Immunology 2013 74 7 818 827
125. Rizzo R., Bortolotti D., Fredj N. B., Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of s HLA-G molecules in relapsing-remitting multiple sclerosis. Human Immunology 2012 73 11 1140 1146
126. Rousseau P., Le Discorde M., Mouillot G., Marcou C., Carosella E. D., Moreau P., The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G mRNA stability. Human Immunology 2003 64 11 1005 1010 2-s2.0-0242609928 10.1016/j.humimm.2003.08.347 (Pubitemid 37413707)
127. O'Brien M., McCarthy T., Jenkins D., Paul P., Dausset J., Carosella E. D., Moreau P., Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cellular and Molecular Life Sciences 2001 58 12-13 1943 1949 2-s2.0-0035197109 (Pubitemid 33108779)
128. Hviid T. V. F., Hylenius S., Rørbye C., Nielsen L. G., HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003 55 2 63 79 2-s2.0-0037793279 (Pubitemid 36702743)
129. Tan Z., Randall G., Fan J., Camoretti-Mercado B., Brockman-Schneider R., Pan L., Solway J., Gern J. E., Lemanske R. F. Jr., Nicolae D., Ober C., Allele-specific targeting of microRNAs to HLA-G and risk of asthma. American Journal of Human Genetics 2007 81 4 829 834 2-s2.0-35348992063 10.1086/521200 (Pubitemid 47596550)
130. Veit T. D., Chies J. A. B., Tolerance versus immune response-MicroRNAs as important elements in the regulation of the HLA-G gene expression. Transplant Immunology 2009 20 4 229 231 2-s2.0-59649114764 10.1016/j.trim.2008.11.001
131. Bortolotti D., Gentili V., Melchiorri L., Rotola A., Rizzo R., An accurate and reliable real time SNP genotyping assay for the HLA-G +3142 bp C>G polymorphism. Tissue Antigens 2012 80 3 259 262
132. Zambra F. M. B., Chies J. A. B., Alho C. S., Veit T. D., Response to Bortolotti et al. 2012-a re-evaluation of our polymerase chain reaction-restriction fragment length polymorphism genotyping method. Tissue Antigens 2013 82 4 286 287
133. Nicodemus-Johnson J., Laxman B., Stern R. K., Maternal asthma and microRNA regulation of soluble HLA-G in the airway. Journal of Allergy and Clinical Immunology 2013 131 6 1496 1503
134. Manaster I., Goldman-Wohl D., Greenfield C., Nachmani D., Tsukerman P., Hamani Y., Yagel S., Mandelboim O., MiRNA-mediated control of HLA-G expression and function. PLoS ONE 2012 7 3, article e33395 2-s2.0-84858416153 10.1371/journal.pone.0033395
135. Kulkarni S., Savan R., Qi Y., Gao X., Yuki Y., Bass S. E., Martin M. P., Hunt P., Deeks S. G., Telenti A., Pereyra F., Goldstein D., Wolinsky S., Walker B., Young H. A., Carrington M., Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 2011 472 7344 495 498 2-s2.0-79955542187 10.1038/nature09914
136. Yie S.-M., Li L.-H., Xiao R., Librach C. L., A single base-pair mutation in the 3′-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Molecular Human Reproduction 2008 14 11 649 653 2-s2.0-57649152984 10.1093/molehr/gan059
137. Wang X., Li B., Wang J., Evidence that miR-133a causes recurrent spontaneous abortion by reducing HLA-G expression. Reproductive BioMedicine Online 2012 25 4 415 424
138. Martelli-Palomino G., Pancotto J. A., Muniz Y. C., Polymorphic sites at the 3′ untranslated region of the HLA-G gene are associated with differential HLA-G soluble levels in the Brazilian and French population. PLoS One 2013 8 10, article e71742
139. Mendes C. T. Jr., Castelli E. C., Meyer D., Simões A. L., Donadi E. A., Genetic diversity of the HLA-G coding region in Amerindian populations from the Brazilian Amazon: a possible role of natural selection. Genes & Immunity 2013 14 8 518 526
140. Mendes C. T. Jr., Castelli E. C., Simões R. T., Simões A. L., Donadi E. A., HLA-G 14-bp polymorphism at exon 8 in Amerindian populations from the Brazilian Amazon. Tissue Antigens 2007 69 3 255 260 2-s2.0-34247857423 10.1111/j.1399-0039.2006.00797.x (Pubitemid 46696946)
141. Yang J. Q., Remmers E. F., Marcu K. B., The first exon of the c-myc proto-oncogene contains a novel positive control element. EMBO Journal 1986 5 13 3553 3562 2-s2.0-0023054105
142. James-Pederson M., Yost S., Shewchuk B., Zeigler T., Miller R., Hardison R., Flanking and intragenic sequences regulating the expression of the rabbit α -globin gene. Journal of Biological Chemistry 1995 270 8 3965 3973 2-s2.0-0028931858 10.1074/jbc.270.8.3965
143. Neznanov N., Umezawa A., Oshima R. G., A regulatory element within a coding exon modulates keratin 18 gene expression in transgenic mice. Journal of Biological Chemistry 1997 272 44 27549 27557 2-s2.0-0030783250 10.1074/jbc.272.44.27549 (Pubitemid 27473545)
144. Pravica V., Perrey C., Stevens A., Lee J.-H., Hutchinson I. V., A single nucleotide polymorphism in the first intron of the human IFN- γ gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN- γ production. Human Immunology 2000 61 9 863 866 2-s2.0-0033787711 10.1016/S0198-8859(00)00167-1
145. Bream J. H., Carrington M., O'Toole S., Dean M., Gerrard B., Shin H. D., Kosack D., Modi W., Young H. A., Smith M. W., Polymorphisms of the human IFNG gene noncoding regions. Immunogenetics 2000 51 1 50 58 2-s2.0-0034016053 (Pubitemid 30150959)
146. Do T. N., Ucisik-Akkaya E., Davis C. F., Morrison B. A., Dorak M. T., An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males. Biochimica et Biophysica Acta 2010 1802 2 292 300 2-s2.0-74149093117 10.1016/j.bbadis.2009.10.015
147. Ishitani A., Geraghty D. E., Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proceedings of the National Academy of Sciences of the United States of America 1992 89 9 3947 3951 2-s2.0-0026575821
148. Paul P., Adrian Cabestre F., Ibrahim E. C., Lefebvre S., Khalil-Daher I., Vazeux G., Moya Quiles R. M., Bermond F., Dausset J., Carosella E. D., Identification of HLA-G 7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G 5, -G6, and -G7 transcripts in human transfected cells. Human Immunology 2000 61 11 1138 1149 2-s2.0-0034516969 10.1016/S0198-8859(00)00197-X (Pubitemid 32043892)
149. Fujii T., Ishitani A., Geraghty D. E., A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. Journal of Immunology 1994 153 12 5516 5524 2-s2.0-0028116211 (Pubitemid 24377687)
150. Suárez M. B., Morales P., Castro M. J., Fernández V., Varela P., Alvarez M., Martínez-Laso J., Arnaiz-Villena A., A new HLA-G allele (HLA-G ()0105N) and its distribution in the Spanish population. Immunogenetics 1997 45 6 464 465 2-s2.0-0030978627 10.1007/s002510050235 (Pubitemid 27163193)
151. Mendes C. T. Jr., Castelli E. C., Simões A. L., Donadi E. A., Absence of the HLA-G 0105N allele in Amerindian populations from the Brazilian Amazon Region: a possible role of natural selection. Tissue Antigens 2007 70 4 330 334 2-s2.0-34548344006 10.1111/j.1399-0039.2007.00910.x (Pubitemid 47340737)
152. Lajoie J., Jeanneau A., Faucher M.-C., Moreau P., Roger M., Characterisation of five novel HLA-G alleles with coding DNA base changes. Tissue Antigens 2008 72 5 502 504 2-s2.0-54049127331 10.1111/j.1399-0039.2008. 01130.x
153. Mendes-Junior C. T., Castelli E. C., Moreau P., Simões A. L., Donadi E. A., Absence of the HLA-G 0113N allele in Amerindian populations from the Brazilian Amazon region. Human Immunology 2010 71 4 428 431 2-s2.0-77950532561 10.1016/j.humimm.2010.01.014
154. Ober C., Aldrich C., Rosinsky B., Robertson A., Walker M. A., Willadsen S., Verp M. S., Geraghty D. E., Hunt J. S., HLA-G 1 protein expression is not essential for fetal survival. Placenta 1998 19 2-3 127 132 2-s2.0-0031913341 10.1016/S0143-4004(98)90000-5 (Pubitemid 28112195)
155. Matte C., Lacaille J., Zijenah L., Ward B., Roger M., HLA-G exhibits low level of polymorphism in indigenous East Africans. Human Immunology 2002 63 6 495 501 2-s2.0-0035985659 10.1016/S0198-8859(02)00391-9 (Pubitemid 34620086)
156. Castro M. J., Morales P., Rojo-Amigo R., Martinez-Laso J., Allende L., Varela P., Garcia-Berciano M., Guillen-Perales J., Arnaiz-Villena A., Homozygous HLA-G 0105N healthy individuals indicate that membrane-anchored HLA-G 1 molecule is not necessary for survival. Tissue Antigens 2000 56 3 232 239 2-s2.0-0033811849 10.1034/j.1399-0039.2000.560305.x
157. Simões R. T., Gonçalves M. A., Castelli E. C., HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Modern Pathology 2009 22 8 1075 1082
158. Arnaiz-Villena A., Enriquez-de-Salamancaa M., Areces C., HLA-G ()01: 05N null allele in Mayans (Guatemala) and Uros (Titikaka Lake, Peru): evolution and population genetics. Human Immunology 2013 74 4 478 482
159. Abbas A., Tripathi P., Naik S., Agrawal S., Analysis of human leukocyte antigen (HLA)-G polymorphism in normal women and in women with recurrent spontaneous abortions. European Journal of Immunogenetics 2004 31 6 275 278 2-s2.0-9644264330 10.1111/j.1365-2370.2004.00487.x (Pubitemid 39572287)
160. Aldrich C., Wambebe C., Odama L., Di Rienzo A., Ober C., Linkage disequilibrium and age estimates of a deletion polymorphism (1597ΔC) in HLA-G suggest non-neutral evolution. Human Immunology 2002 63 5 405 412 2-s2.0-0036097577 10.1016/S0198-8859(02)00377-4 (Pubitemid 34521372)